Subscribe to Here’s the Deal, our politics
newsletter for analysis you won’t find anywhere else.
Thank you. Please check your inbox to confirm.
Leave your feedback
Friday on the NewsHour, a congressional committee makes six years of former President Trump's tax returns public. The FDA is criticized for breaking protocol during its approval process for a new Alzheimer's drug. Plus, David Brooks and Jonathan Capehart weigh in on the biggest political headlines of 2022 and what to expect in the new year.
Support Provided By: